Clinical Trials Directory

Trials / Completed

CompletedNCT01381302

Trodat 1 SPECT and Dopamine Polymorphism

Association of Polymorphism in Genes Associated With Control of Dopamine Levels in Parkinson's Disease and Tc-99m-Trodat-1 SPECT Imaging.

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Wolfson Medical Center · Other Government
Sex
All
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study population will include 100 parkinsonian patients in early stage of disease, with total duration not exeeding 5 years. The patients will undergo neurologic examination and evaluation of disease severity using the unified PD rating scale. Subsequently a brain SPECT will be performed using Tc-99m-Trodat1.

Detailed description

The study sample will include 100 Israeli Jewish patients with early idiopathic PD who were not treated with anti-parkinson drugs. The clinical diagnosis will be based on the criteria of the United Kingdom Parkinson Disease Society Brain Bank.5 All patients will undergo Tc-99m-Trodat1 SPECT. The severity of the motor symptoms will be assessed with the Unified PD Rating Scale (UPDRS). Genomic DNA is extracted from peripheral blood leukocytes for genetic analysis.

Conditions

Timeline

Start date
2011-08-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2011-06-27
Last updated
2016-02-09

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT01381302. Inclusion in this directory is not an endorsement.